Search
Research
ViPAR: A software platform for the Virtual Pooling and Analysis of Research DataViPAR is a secure, flexible and powerful analysis platform built on open source technology that is currently in use by large international consortia
Research
Declining transition rates to psychotic disorder in "ultra-high risk" clients: Investigation of a dilution effectLater ultra-high risk psychosis cohorts presented with different clinical intake characteristics than earlier cohorts
Research
Skin tumor immunity: Site does matter for antigen presentation by DCsTimely mobilization of tumor antigen-bearing dendritic cells (DCs) from the periphery to the lymph nodes is critical for effective antitumor T-cell immunity
Research
Pediatric sepsis in the developing world.Sepsis is the leading killer of children worldwide, but this is not reflected in estimates of global mortality.
Research
TOBY play-pad application to teach children with ASD-A pilot trial.To investigate use patterns and learning outcomes associated with the use of Therapy Outcomes By You (TOBY. Playpad, an early intervention iPad application.
Research
Medulloblastoma Down Under 2013: a report from the third annual meeting of the International Medulloblastoma Working GroupMedulloblastoma is curable in approximately 70 % of patients. Over the past decade, progress in improving survival using conventional therapies has stalled...
Research
Evidence for the use of an algorithm in resolving inconsistent and missing Indigenous status in administrative data collectionsWe found that algorithms reduced the amount of missing data and improved within‑individual consistency.
Research
Experience of gastrostomy using a quality care framework: The example of rett syndromeGastrostomy assisted the management of feeding difficulties and poor weight gain, and was acceptable to families
Research
Pubertal trajectory in females with Rett syndrome: A population-based studyThe aim of this study was to describe pubertal development in a population-based cohort of females with Rett syndrome.
Research
Effectiveness of Palivizumab in Preventing RSV Hospitalization in High Risk Children: A Real-World PerspectiveThis review supports the recommended use of palivizumab for reducing RSV-associated hospitalisation rates in premature babies born at gestational age <33 weeks.